Diffuse Large B-Cell Lymphoma

被引:612
|
作者
Sehn, Laurie H. [1 ,2 ]
Salles, Gilles [3 ]
机构
[1] BC Canc Ctr Lymphoid Canc, 600 W 10th Ave, Vancouver, BC V5Z 4E6, Canada
[2] Univ British Columbia, Vancouver, BC, Canada
[3] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2021年 / 384卷 / 09期
关键词
RITUXIMAB PLUS CYCLOPHOSPHAMIDE; NON-HODGKIN-LYMPHOMA; PHASE-III TRIAL; ELDERLY-PATIENTS; RESPONSE ASSESSMENT; SINGLE-ARM; OPEN-LABEL; R-CHOP; CYCLES; MULTICENTER;
D O I
10.1056/NEJMra2027612
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:842 / 858
页数:17
相关论文
共 50 条
  • [1] Translating the Biology of Diffuse Large B-cell Lymphoma Into Treatment
    Danilov, Alexey, V
    Magagnoli, Massimo
    Matasar, Matthew J.
    ONCOLOGIST, 2022, 27 (01): : 57 - 66
  • [2] Treatment strategies for patients with diffuse large B-cell lymphoma
    Poletto, Stefano
    Novo, Mattia
    Paruzzo, Luca
    Frascione, Pio Manlio Mirko
    Vitolo, Umberto
    CANCER TREATMENT REVIEWS, 2022, 110
  • [3] Real-world data for lenalidomide maintenance in responding patients of diffuse large B-cell lymphoma
    Wang, Xiaoyan
    Yu, Lu
    Jiang, Xinlu
    Ding, Kaiyang
    CANCER MEDICINE, 2023, 12 (09): : 10553 - 10562
  • [4] Treatment resistance in diffuse large B-cell lymphoma
    He, Michael Y.
    Kridel, Robert
    LEUKEMIA, 2021, 35 (08) : 2151 - 2165
  • [5] Antibody and immunotherapy in diffuse large B-cell lymphoma
    Barraclough, Allison
    Hawkes, Eliza A.
    SEMINARS IN HEMATOLOGY, 2023, 60 (05) : 338 - 345
  • [6] Navigating the Evolving Treatment Landscape of Diffuse Large B-Cell Lymphoma
    Nastoupil, Loretta J.
    Bartlett, Nancy L.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (04) : 903 - +
  • [7] Diffuse large B-cell lymphoma
    Barraclough, Allison
    Hawkes, Eliza
    Sehn, Laurie H.
    Smith, Sonali M.
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (06)
  • [8] New Insights into First-Line Therapy in Diffuse Large B-Cell Lymphoma: Are We Improving Outcomes?
    Abrisqueta, Pau
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (07)
  • [10] Tafasitamab for the treatment of patients with diffuse large B-cell lymphoma
    Pirosa, Maria Cristina
    Stathis, Anastasios
    Zucca, Emanuele
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)